| Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer M Javle, Y Li, D Tan, X Dong, P Chang, S Kar, D Li PloS one 9 (1), e85942, 2014 | 153 | 2014 |
| Circulating microRNAs in pancreatic juice as candidate biomarkers of pancreatic cancer J Wang, M Raimondo, S Guha, J Chen, L Diao, X Dong, MB Wallace, ... Journal of Cancer 5 (8), 696, 2014 | 135 | 2014 |
| Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer D Li, EJ Duell, K Yu, HA Risch, SH Olson, C Kooperberg, BM Wolpin, ... Carcinogenesis 33 (7), 1384-1390, 2012 | 130 | 2012 |
| Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer X Chen, Q Meng, Y Zhao, M Liu, D Li, Y Yang, L Sun, G Sui, L Cai, ... Cancer letters 328 (2), 318-324, 2013 | 122 | 2013 |
| Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway J Han, B Han, X Wu, J Hao, X Dong, Q Shen, H Pang Toxicology and applied pharmacology 359, 55-61, 2018 | 116 | 2018 |
| Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer M Tanaka, M Javle, X Dong, C Eng, JL Abbruzzese, D Li Cancer 116 (22), 5325-5335, 2010 | 107 | 2010 |
| MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma K Qu, Z Wang, H Fan, J Li, J Liu, P Li, Z Liang, H An, Y Jiang, Q Lin, ... Cell death & disease 8 (2), e2603-e2603, 2017 | 103 | 2017 |
| Body mass index and obesity-and diabetes-associated genotypes and risk for pancreatic cancer H Tang, X Dong, M Hassan, JL Abbruzzese, D Li Cancer epidemiology, biomarkers & prevention 20 (5), 779-792, 2011 | 99 | 2011 |
| ABCC3 as a marker for multidrug resistance in non-small cell lung cancer Y Zhao, H Lu, A Yan, Y Yang, Q Meng, L Sun, H Pang, C Li, X Dong, L Cai Scientific reports 3 (1), 3120, 2013 | 85 | 2013 |
| A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma A Aihara, CK Huang, MJ Olsen, Q Lin, W Chung, Q Tang, X Dong, ... Hepatology 60 (4), 1302-1313, 2014 | 83 | 2014 |
| ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis Q Lin, X Chen, F Meng, K Ogawa, M Li, R Song, S Zhang, Z Zhang, ... Molecular cancer 18, 1-17, 2019 | 78 | 2019 |
| Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer H Pang, H Lu, H Song, Q Meng, Y Zhao, N Liu, F Lan, Y Liu, S Yan, ... Cancer epidemiology 37 (6), 985-992, 2013 | 73 | 2013 |
| Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia YB Zhang, J Hu, J Zhang, X Zhou, X Li, C Gu, T Liu, Y Xie, J Liu, M Gu, ... Nature communications 7 (1), 10605, 2016 | 70 | 2016 |
| Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer C Nadolny, X Dong Cancer biology & therapy 16 (7), 997-1004, 2015 | 69 | 2015 |
| Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer X Dong, M Javle, KR Hess, R Shroff, JL Abbruzzese, D Li Gastroenterology 139 (2), 464-473. e3, 2010 | 64 | 2010 |
| Aspartate β‐hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma Y Iwagami, CK Huang, MJ Olsen, JM Thomas, G Jang, M Kim, Q Lin, ... Hepatology 63 (4), 1213-1226, 2016 | 62 | 2016 |
| Ang II–AT1R increases cell migration through PI3K/AKT and NF‐κB pathways in breast cancer Y Zhao, H Wang, X Li, M Cao, H Lu, Q Meng, H Pang, H Li, C Nadolny, ... Journal of cellular physiology 229 (11), 1855-1862, 2014 | 62 | 2014 |
| Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer H Tang, X Dong, RS Day, MM Hassan, D Li Carcinogenesis 31 (4), 607-613, 2010 | 60 | 2010 |
| Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer H Suzuki, Y Li, X Dong, MM Hassan, JL Abbruzzese, D Li Cancer Epidemiology Biomarkers & Prevention 17 (12), 3467-3473, 2008 | 58 | 2008 |
| Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion J Ao, J Meng, L Zhu, H Nie, C Yang, J Li, J Gu, Q Lin, W Long, X Dong, ... Molecular oncology 6 (5), 507-515, 2012 | 57 | 2012 |
